FibroBiologics
June 16, 2025
Company Presentation
Regenerative Medicine
Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 240+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.
Company HQ City:
Houston
Company HQ State:
TX
Company HQ Country:
United States
Year Founded:
2021
Lead Product in Development:
CYWC628 Wound Care
CEO
Pete O'Heeron
Development Phase of Lead Product
Phase I
Number of Unlicensed Products Looking for Licensing
5
Exchange
Nasdaq
Ticker
FBLG
When you expect your next catalyst update?
Interim results from our wound care trial.
What is your next catalyst (value inflection) update?
July/Aug 2025
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}